Log In|Sign Up
ENLipodystrophy, Congenital Generalized, Type 2 (CGL2)
Alias:
Congenital Generalized Lipodystrophy Type 2
Cgl2
Berardinelli-Seip Congenital Lipodystrophy Type 2
Total Lipodystrophy and Acromegaloid Gigantism
Brunzell Syndrome Bscl2-Related
Berardinelli-Seip Syndrome
Lipodystrophy, Berardinelli-Seip Congenital, Type 2
Berardinelli-Seip Congenital Lipodystrophy, Type 2
Lipodystrophy, Total, and Acromegaloid Gigantism
Congenital Generalized Lipodystrophy 2
Familial Partial Lipodystrophy, Type 2
Familial Generalized Lipodystrophy
Lipoatrophic Diabetes, Congenital
Brunzell Syndrome, Bscl2-Related
Congenital Lipoatrophic Diabetes
Lipodystrophy Berardinelli Type
Lipoatrophic Diabetes Mellitus
Lipoatrophic Diabetes
Berardinelli Syndrome
Seip Syndrome
Favorite
Lipodystrophy, Congenital Generalized, Type 2, also known as congenital generalized lipodystrophy type 2, is related to lipodystrophy, congenital generalized, type 1 and lipodystrophy, congenital generalized, type 3, and has symptoms including myalgia An important gene associated with Lipodystrophy, Congenital Generalized, Type 2 is BSCL2 (BSCL2 Lipid Droplet Biogenesis Associated, Seipin), and among its related pathways/superpathways are Metabolism and Glucose / Energy Metabolism. The drugs Empagliflozin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include bone and liver, and related phenotypes are acanthosis nigricans and reduced subcutaneous adipose tissue
Related ID：
Basic Information
Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
Medical Symptom
#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
Gene & Mutation
#
Gene
Function
Score
Mutations
Related Drugs
Name
CAS Number
Status
Phase
Disease Model
Category
Name
MGI
Related Gene
Strain of Origin
Publications
References Literature
Title
PMID
Journal
Year
IF
